Physicians to adjust medications appropriately Large untapped market (24+ million patients) Substantial Revenue Generation Capability with Existing 510(k) PD2i Analyzer(tm) Product Sales Launch Q1 2010 PD2i Analyzer 510(k) Marketing Clearance 12/29/08 Rapid, accurate and economical for new healthcare system Risk stratification of large target patient populations PD2i Analyzer(tm) is a Revolutionary Diagnostic Technology
No obligation to update the results of these forward-looking statements to reflect events orĬircumstances after today or to reflect the occurrence of unanticipated events. Subsequent filings with the Securities and Exchange Commission. Identified in our Annual Report on Form 10-K for the fiscal year ended Decemand Market conditions in the medical device and pharmaceutical industries and other factors Our intellectual property product liability federal income tax laws and regulations general
Key personnel our ability to market and sell our products successfully our ability to protect Third-party manufacturers to manufacture our products our ability to retain the services of our
Organizations to perform preclinical testing and clinical trial for our technologies our ability of Receive regulatory approval for our products the ability of third-party contract research
Reimbursement for our products the impact of competitive products and pricing the ability to On our technologies our ability to obtain and maintain adequate levels of third-party Our ability to continue as a going concern our ability to successfully develop products based To receive financing sufficient to continue operations and complete the critical clinical trials Of the PD2i Analyzer our ability to obtain FDA marketing clearance on the PD2i VS for militaryĪnd civilian applications and the PD2i-CA for total and cardiac mortality our ability to continue Actual results could vary materially from thoseĮxpected due to a variety of risk factors, including our ability to generate revenue from the sale Signaled by forms of words such as should, could, will, might, plan, projection, forecast,Įxpect, guidance, potential and developing. This presentation contains forward-looking statements. The Commercialization Of Breakthrough Risk A Medical Diagnostic Company Dedicated to